India has developed a lot in the past decade or so, but still, it is one of the countries of the “third world”, with a lot of poor and uneducated population, hunger, and places that still have no proper electricity, supermarkets, and hospitals…
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
An American pulmonary and critical care specialist, Dr. Pierre Kory is the founder of the ‘Front Line COVID-19 Critical Care Alliance’ is now a 501(c)(3) non-profit organization dedicated to developing highly effective treatment protocols to prevent the transmission of COVID-19 and to improve the outcomes for patients ill with the disease. He is the “main culprit” that managed to end the COVID “plandemia” in most of India.
“Cases are rare, deaths near zero – in Indian states which use ivermectin in early treatment protocols.
In Uttar Pradesh, India, 33 districts have been declared “Covid-free.” With a combined population of 241 million, there are only 199 active cases and the positive test rate is 0.01% – statistically zero. It is a poor state and worse, the most-populous in the nation and has extremely high-density cities — the most-fertile environment imaginable for a pandemic virus — yet they defeated Covid with a cheap, widely-available drug.”
And, according to the report published by The Desert Review,
“The New York Times reported India’s colossal drop in Covid cases was unexplainable, while the BBC declared that Kerala’s rise was also a mystery. While new cases of Covid in Uttar Pradesh are rare as million-dollar lottery tickets, in Kerala, a tiny state located in southern India, new daily cases are the same as the United States, nearly one case per thousand. Yet, as we have seen in this series, there has been a curious media blackout on India’s overall success against Covid … So, what could Kerala be doing wrong? Hint: Over-reliance on vaccines and under-reliance on ivermectin.”
Last year, India developed a “miraculously” effective and safe Covid treatment kit – containing zinc, doxycycline, and ivermectin – costing merely $2.65 (£1.93) per person. As early as March 2020, India recommended hydroxychloroquine (“HCQ”) in its national guidelines affirming it “should be used as early in the disease course as possible.” But following the June 2020 discovery of ivermectin’s efficacy in treating the virus, Uttar Pradesh announced in August 2020 that it was replacing their HCQ protocol with ivermectin for the prevention and treatment of COVID.”
But, why would they do this?
Why would they push expensive vaccine research and make the entire world use them?!
Because drug companies are getting ready to launch expensive new anti-viral pills that can provide early outpatient treatment for Covid and perhaps even be used preventatively. Yet, ivermectin remains effective, cheap, and safe and thus poses a huge threat to their profits.